• Meet the Oryn Team

    Oryn Therapeutics

Leadership Team

Robert Erwin

Chief Executive Officer, Chairman

James Mullaney

Chief Financial & Chief Operating Officer, Director

Richard Selsted

Chief Business Officer, Director

Michael Selsted, M.D., Ph.D.

Chief Scientific Officer

Percio S. Gulko, M.D.

Chief Medical Officer

Roman Bradel, PhD

Senior Director, Regulatory Affairs

Donna Cabral-Lilly, PhD

Vice President, CMC

Charlene Coyne, MPA

Senior Director, Program Management

Shyamal Das, MD, PhD

Vice President, Clinical Development

Jennifer Hubbard

Assistant Controller

Lauren Kelly

Senior Scientist, Preclinical

Ana Krtolica, PhD

Senior Vice President, Preclinical Development

Afrodite Lourbakos, PhD

Senior Director, Translational Medicine

Jamie Schatz

Controller

Geeta Srivastava, PhD

Senior Director, CMC

Emile Youssef, MD, PhD

Vice President, Oncology

Board of Directors

Mark Armenante

Director

Robert Erwin

Chairman, Chief Executive Officer

James Mullaney

Director, Chief Financial & Chief Operating Officer

Gary M. Phillips, M.D.

Director

Paul Sekhri

Director

Richard Selsted

Director, Chief Business Officer

Young A. Sohn

Director